See the DrugPatentWatch profile for humulin
Humulin is a brand name for a type of insulin used to treat diabetes. It is a synthetic form of human insulin, meaning it is manufactured in a lab to be identical to the insulin produced naturally by the human pancreas. Humulin is available in different formulations, including rapid-acting, short-acting, intermediate-acting, and long-acting insulins, which are used to manage blood sugar levels [1].
What are the different types of Humulin insulin?
Humulin insulin comes in several forms, each with a different onset, peak, and duration of action. These include:
* Humulin R (Regular): A short-acting insulin that begins to work about 30 minutes after injection, peaks in 2 to 4 hours, and lasts for about 6 to 8 hours. It is typically taken before meals [1].
* Humulin N (NPH): An intermediate-acting insulin that begins to work 1 to 3 hours after injection, peaks in 6 to 10 hours, and lasts for about 12 to 16 hours. It is often combined with rapid-acting or short-acting insulins [1].
* Humulin L (Lente): An intermediate-acting insulin that begins to work 1 to 3 hours after injection, peaks in 6 to 10 hours, and lasts for about 12 to 16 hours. While similar to Humulin N, Lente is less commonly used now [1].
* Humulin U (Ultralente): A long-acting insulin that begins to work 4 to 6 hours after injection, peaks in 10 to 16 hours, and lasts for 20 to 24 hours. It provides basal insulin coverage and is often taken at bedtime [1].
* Humulin 70/30: A mixture of 70% NPH insulin and 30% regular insulin, offering both intermediate and short-acting coverage in a single injection [1].
How is Humulin insulin administered?
Humulin insulins are typically administered via subcutaneous injection, meaning they are injected into the fatty tissue just under the skin. Common injection sites include the abdomen, thighs, buttocks, and upper arms. Patients are usually instructed on how to properly inject the insulin themselves [1].
What are the potential side effects of Humulin insulin?
The most common side effect of Humulin insulin, like other insulins, is hypoglycemia, or low blood sugar. Symptoms can include sweating, shaking, dizziness, hunger, and confusion. Other potential side effects can include injection site reactions like redness, swelling, or pain, and less commonly, lipodystrophy (changes in fat tissue at the injection site) [1].
When does Humulin insulin's patent protection expire?
Information regarding specific patent expiry dates for Humulin formulations would require a detailed search of patent databases. Generally, many of the original patents for Humulin insulins have expired, allowing for the potential development of biosimilar insulins. DrugPatentWatch.com provides resources for tracking drug patent information [2].
How does Humulin insulin compare to other insulin brands?
Humulin is a synthetic human insulin. Other insulin brands include those made from recombinant DNA technology or modified human insulins, which can offer different pharmacokinetic profiles (onset, peak, duration). For example, rapid-acting insulins like Humalog and Novolog have a faster onset and shorter duration than Humulin R. Long-acting insulins like Lantus and Levemir provide a more continuous basal insulin coverage compared to intermediate-acting insulins like Humulin N [1].
Who manufactures Humulin insulin?
Humulin insulin is manufactured by Eli Lilly and Company [1].